Molson Coors (TAP) Q1 results reflect on-premise keg sales returns and reimbursements due to the coronavirus pandemic as well as unfavorable mix.
Molson Coors (TAP) delivered earnings and revenue surprises of 16.67% and -3.22%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Molson Coors (TAP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molson Coors (TAP) launches Movo, a new line of canned wine spritzers, in the United States. It also forms a JV with HEXO to explore opportunities for CBD-infused beverages in Colorado.
Diageo (DEO) withdraws FY20 view, cuts expenses and suspends share repurchase plan in the wake of the uncertain COVID-19 impacts. Also, its top line remains soft due to lockdown in many countries.
Constellation Brands (STZ) shares have surged 40% in the last week. So now might be time for investors to consider buying the Corona beer maker's stock before it reports its Q4 fiscal 2020 results on Friday, April 3...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
TAP vs. BF.B: Which Stock Is the Better Value Option?
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dow Drops 10% as Market Looks for Help from Government